Covaxin: Why the controversy?
Dr. Shuvomoy Banerjee, PhD; Neucrad Health Desk 15th Jan, 2021 https://youtu.be/TpJCoaJaTN0 Recently, many leading companies from different countries of the...
Dr. Shuvomoy Banerjee, PhD; Neucrad Health Desk 15th Jan, 2021 https://youtu.be/TpJCoaJaTN0 Recently, many leading companies from different countries of the...
Dr. Shuvomoy Banerjee, PhD.; from Neucrad Health desk, August 20,2020 More than 2.6 million people of India are currently infected...
Dr. Shuvomoy Banerjee, PhD, Neucrad Health desk, July 2, 2020 In a time when there are only around 17 experimental...